Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
DMK PHARMACEUTICALS Corp has filed 1,210 SEC EDGAR filings since 13 Feb 1996

SEC filing history

Showing 701-725 of 775 matching filings.

Per page
25
Current page
29
8-K File 000-26372

CURRENT REPORT

Filing date
05 Apr 2012
Reporting date
02 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-26372

QUARTERLY REPORT

Filing date
14 Feb 2012
Reporting date
31 Dec 2011
Next action
Verify source filing
8-K File 000-26372

CURRENT REPORT

Filing date
06 Feb 2012
Reporting date
31 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-45279

SC 13D/A

Filing date
03 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-26372

QUARTERLY REPORT

Filing date
21 Nov 2011
Reporting date
30 Sep 2011
Next action
Verify source filing
SC 13D/A File 005-45279

FORM SC 13D/A

Filing date
21 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q/A File 000-26372

NOTIFICATION OF LATE FILING

Filing date
15 Nov 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26372

CURRENT REPORT

Filing date
04 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26372

CURRENT REPORT

Filing date
16 Sep 2011
Reporting date
15 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
16 Sep 2011
Reporting date
12 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Sep 2011
Reporting date
12 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
16 Sep 2011
Reporting date
02 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
16 Sep 2011
Reporting date
02 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filing date
15 Sep 2011
Reporting date
12 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Sep 2011
Reporting date
12 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Sep 2011
Reporting date
12 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Sep 2011
Reporting date
13 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Sep 2011
Reporting date
13 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Sep 2011
Reporting date
13 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-26372

QUARTERLY REPORT

Filing date
15 Aug 2011
Reporting date
30 Jun 2011
Next action
Verify source filing
DEF 14A File 000-26372

DEFINITIVE PROXY STATEMENT

Filing date
08 Aug 2011
Reporting date
12 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 000-26372

AMENDMENT TO ANNUAL REPORT

Filing date
29 Jul 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26372

CURRENT REPORT

Filing date
28 Jul 2011
Reporting date
28 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-45279

SC 13D/A filing

Filing date
26 Jul 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-26372

CURRENT REPORT

Filing date
07 Jul 2011
Reporting date
30 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .